tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Ascentage Pharma initiated with a Buy at Lucid Capital
PremiumThe FlyAscentage Pharma initiated with a Buy at Lucid Capital
2M ago
Ascentage Pharma Showcases Promising Data for Olverembatinib at ASH 2025
Premium
Company Announcements
Ascentage Pharma Showcases Promising Data for Olverembatinib at ASH 2025
2M ago
Ascentage Pharma Unveils Promising Lisaftoclax Data at ASH 2025
Premium
Company Announcements
Ascentage Pharma Unveils Promising Lisaftoclax Data at ASH 2025
2M ago
Ascentage Pharma to Highlight Key Data from ASH 2025 in Upcoming Webcast
PremiumCompany AnnouncementsAscentage Pharma to Highlight Key Data from ASH 2025 in Upcoming Webcast
2M ago
Ascentage Pharma Announces New RSU and Share Option Grants
Premium
Company Announcements
Ascentage Pharma Announces New RSU and Share Option Grants
2M ago
Ascentage Pharma’s Olverembatinib Shows Promise in Rare GIST Treatment
Premium
Company Announcements
Ascentage Pharma’s Olverembatinib Shows Promise in Rare GIST Treatment
2M ago
Ascentage Pharma initiated with an Overweight at Piper Sandler
PremiumThe FlyAscentage Pharma initiated with an Overweight at Piper Sandler
3M ago
Promising Potential of Ascentage Pharma’s Key Assets: Olverembatinib and Lisaftoclax Drive Buy Rating Amidst Risks
Premium
Ratings
Promising Potential of Ascentage Pharma’s Key Assets: Olverembatinib and Lisaftoclax Drive Buy Rating Amidst Risks
3M ago
Ascentage Pharma to Engage Investors at November Conferences
Premium
Company Announcements
Ascentage Pharma to Engage Investors at November Conferences
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100